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Abstract: Aging is accompanied by a progressive decline in muscle mass and an increase in fat mass,
which are detrimental changes associated with the development of health conditions such as type-2
diabetes mellitus or chronic low-grade inflammation. Although both exercise as well as nutritional
interventions are known to be beneficial in counteracting those age-related changes, data to which
extent untrained elderly people may benefit is still sparse. Therefore, a randomized, controlled,
12-week interventional trial was conducted in which 134 healthy untrained participants (96 women
and 38 men, age 59.4 ± 5.6 years, body mass index (BMI) 28.4 ± 5.8 kg/m2) were allocated to one of
four study groups: (1) control group with no intervention (CON); (2) 2×/week aerobic and resistance
training only (EX); (3) exercise routine combined with dietary counseling in accordance with the
guidelines of the German Nutrition Society (EXDC); (4) exercise routine combined with intake of
2 g/day oil from Calanus finmarchicus (EXCO). Body composition (bioelectrical impedance analysis), as
well as markers of glucose metabolism and blood lipids, were analyzed at the beginning and the end
of the study. The highest decreases in body fat were observed within the EXCO group (−1.70 ± 2.45 kg,
p < 0.001), and the EXDC (−1.41 ± 2.13 kg, p = 0.008) group. Markers of glucose metabolism and
blood lipids remained unchanged in all groups. Taken together results of this pilot study suggest that
a combination of moderate exercise and intake of oil from Calanus finmarchicus or a healthy diet may
promote fat loss in elderly untrained overweight participants.
Keywords: aging; exercise; obesity; omega-3 fatty acid; body composition; fat loss; glucose metabolism
1. Introduction
Aging is accompanied by changes in body composition, which include a progressive decline in
muscle mass as well as an increase in body fat mass [1]. If not counteracted, those changes may have
multiple health consequences such as development of obesity, type-2 diabetes, chronic low-grade
inflammation, or cardiovascular diseases [1–3]. Regular exercise is known to prevent, attenuate and
even reverse the described changes [4–6] as it helps to prevent muscle loss, build new muscle mass,
and reduce adipocyte cell size and lipid content [7]. Moreover, it has broad beneficial effects on human
energy metabolism and glucose control as it elicits contraction-induced, insulin-independent glucose
uptake in skeletal muscle [8,9].
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However, body composition and metabolic markers are also largely influenced by the diet. A diet
that is high in energy and high glycemic foods may facilitate the development of obesity, cardiovascular
diseases or diabetes [10,11]. Conversely, a nutrient-dense diet providing adequate intake of macro- and
micronutrients, fiber, and phytochemicals can help to prevent those diseases and support the beneficial
effects of exercise [12–16]. To promote such “healthy diet”, the German Nutrition Society recommends
a diet rich in vegetables, fruits, whole grain cereal products, daily intake of dairy products, moderate
meat intake and 1–2 portions of fish per week [17].
On the other hand, there are also individual nutrients, which have been shown to positively
influence body composition as well as metabolic markers. In that regard, results from several studies
demonstrated that supplementation of omega-3 polyunsaturated fatty acids (n-3 PUFAs) potentially
reduces fasting insulin levels in diabetic individuals and positively influences body composition by
supporting body weight loss [18–21]. Moreover, n-3 PUFAs are also linked to increases in muscle
mass and muscle function in healthy older adults [20]. One novel source of n-3 PUFAs that showed
promising effects on the reduction of abdominal fat and glucose control in animal studies is the oil
from the copepod Calanus finmarchicus [22,23]. Of all fatty acids present in Calanus oil (CO) >80% are
bound as wax esters. In addition to providing n-3 PUFAs such as stearidonic acid (SDA, C18:4n3),
eicosapentaenoic acid (EPA, C20:5n3) and docosahexaenoic acid (DHA, 22:6n3), it also contains plant
sterols and astaxanthin, therefore differing from conventional marine oils. Carotenoids such as
astaxanthin are also discussed to play a role in counteracting obesity [24].
Although synergistic effects of exercise combined with nutritional measures are presumed,
only a few studies have investigated the effects of a combined exercise and nutritional intervention.
Moreover, most of those studies were focused on the pre-diabetic, diabetic, or obese populations
leaving out the elderly untrained but otherwise healthy population [25–27]. Further, no studies have
examined whether and how exercise combined with either a healthy diet versus supplementation of
CO may differ.
Given the information above, we hypothesized that moderate exercise combined with nutritional
measures may result in more favorable changes in body composition and metabolic markers than
exercise alone. Further, we aimed to identify whether one of the two nutritional interventions would
result in greater changes than the other. Therefore, a pilot study was conducted to investigate to which
extent elderly untrained, but otherwise healthy, subjects may benefit in terms of body composition,
glucose control, and blood lipids when performing exercise only or exercise combined with either a
general dietary recommendation or intake of CO.
2. Materials and Methods
2.1. Study Participants
In total, 134 men and women were recruited via advertisements in local newspapers and public
notice boards from the general population in Hannover, Germany between August 2018 and March
2019. The main inclusion criteria for participation were: age ≥ 50 and ≤ 70 years, no exercise training
aside from the daily activities for at least 2 years, a stable body weight (± 5 kg) for at least 6 months,
ability to physically perform the exercise intervention (exercise capacity) and consumption of an
omnivorous diet. Exclusion criteria were defined as suspicion and diagnosis of cardiovascular diseases
(angina pectoris, myocardial infarction, stroke, peripheral arterial occlusive disease, heart failure,
cardiac arrhythmia), type 1 and 2 diabetes, renal insufficiency and liver diseases, blood coagulation
disorders, chronic gastrointestinal disorders (e.g., ulcers, Crohn’s disease), pancreatic insufficiency,
immunological diseases (e.g., autoimmune diseases), intake of immunosuppressive drugs or laxatives,
intake of supplements containing n-3 PUFAs, alcohol, drug and/or medicine dependency, pregnancy
or lactation, retraction of the consent by the subject, concurrent participation in another clinical study,
and participation in a study in the last 30 days. Inclusion and exclusion criteria were assessed using a
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structured screening questionnaire. Cardiovascular health was determined by resting and exercise
electrocardiogram, implemented by trained professionals and a physician.
2.2. Study Design
This single-center, randomized controlled trial in parallel group design was conducted by trained
professionals using standardized methods at the Institute of Food Science and Human Nutrition, Leibniz
University Hannover, Germany. The study involved a screening phase and 12-week intervention phase
with two examination days; one at the beginning (t0) and one at the end of the 12-week intervention
(t12). Additionally, there was a questionnaire-based examination after six weeks (t6).
Ethical approval was provided by the Ethics Commission of the Medical Chamber of Lower
Saxony (Hannover, Germany). In accordance with the guidelines of the Declaration of Helsinki,
written informed consent was obtained from all participants prior to their participation in the study.
This study is registered in the German Clinical Trial Register (DRKS00014322). The participants were
randomly assigned by an independent researcher using stratified randomization according to the
covariates sex, BMI, age (in descending order) to one of the four study groups: (1) control group
(CON), (2) exercise only group (EX), (3) exercise and dietary counseling group (EXDC), (4) exercise
and CO supplementation group (EXCO). The CON group served as control and participants of this
group were asked to maintain their habitual diet and physical activity level throughout the 12-week
investigation period. The EX, EXDC, and EXCO groups were instructed to perform exercise training
twice a week. Participants randomized to the EX group were asked to maintain their normal diet.
Participants randomized to the EXDC group were asked to adapt their diet in accordance with the
dietary guidelines of the German Nutrition Society [17]. Therefore, participants of this group received
an individualized nutrition counseling session by a professional nutritionist at the first examination.
In general, dietary recommendations included the following advice: intake of 3 portions of vegetables
and 2 portions of fruits daily, consumption of cereal products with a focus on whole-grain products,
daily consumption of dairy products such as milk or cheese, limited meat intake of 300–600 g per week,
consumption of fish once or twice a week, limited intake of salt and sugar [17]. In addition to exercise,
participants randomized to the EXCO group were instructed to consume four capsules containing oil
from Calanus finmarchicus (Calanus AS, Tromsø, Norway) daily during the 12-week intervention period.
Therefore, participants received a counted number of capsules and were advised to return leftover
capsules at the end of the study. The leftover capsules were then counted to assess the compliance in
taking the supplement (at least 90% of the capsules had to be consumed). Four capsules provided 2 g of
CO. The composition of the oil is shown in Table 1. Further, participants were asked to maintain their
normal diet. Compliance of participants and adherence to the respective instructions was monitored
within all study groups via fortnightly phone calls.
2.3. Exercise Training
The exercise training was performed in cooperating fitness centers after thorough instructions
from a professional trainer. Each training session consisted of an initial warm-up, followed by two
passes of a strength-endurance circuit.
The strength training consisted of six machine-supported exercises that included all major muscle
groups and were performed for one minute each. During the initial training session, a maximum
force test with three attempts was performed. The best of the three tests was scored and used to
define the exercise intensity at about 60% of the participant’s maximum force for the first two weeks of
training. For the subsequent six weeks, the load was increased by 10% and again by 5% for the last
four weeks. The endurance exercise consisted of a four-minute bout performed on bicycle ergometers
and cross-trainers at a perceived exertion corresponding to an intensity of about 15 on the Borg-Scale.
In between each exercise, the participants had 30 s of rest. Including the warm-up and rest periods,
the training session could be completed in approximately one hour. Compliance of the participants
was assessed via a training log and a questionnaire at the end of the study.
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Table 1. Composition of oil from Calanus finmarchicus.












Fatty alcohols 33,017 660
Astaxanthin 180 3.6
CO = Calanus finmarchicus oil, SFA = Saturated fatty acids; MUFA = Monounsaturated fatty acids; PUFA =
Polyunsaturated fatty acids; ALA = Alpha-Linolenic acid; SDA = Stearidonic acid; EPA = Eisosapentaenoic
acid; DHA = Docosahexaenoic acid; LA = Linoleic acid; ARA = Arachidonic acid. Other minor compounds are
triacylglycerides, free fatty acids, phospholipids and plant sterols.
2.4. Monitoring of Dietary Intake and Physical Activity
The level of regular physical activity outside of the intervention was assessed using the German
Freiburger Questionnaire for Physical Activity at the beginning, after six weeks, and at the end of the
study [28]. Dietary intake of the participants was monitored via 3-day dietary records at the beginning,
after six weeks, and at the end of the study. The records were checked by nutritionists for completeness,
readability, and plausibility. If necessary, ambiguities were clarified with the participants. Energy
and nutrient intake were estimated using the software PRODI6.4 (Nutri-Science GmbH, Freiburg,
Germany). Additionally, consumption of specific food groups was assessed with the food frequency
questionnaire (FFQ) from the German Health Examination Survey for Adults (Studie zur Gesundheit
Erwachsener in Deutschland, DEGS) of the Robert Koch Institute.
2.5. Bodyweight and Body Composition
All measurements were performed under standardized conditions on both days of examination
at the beginning and end of the study. Participants arrived at the institute between 6:00–10 a.m.,
rested, and after an overnight fast (≥10 h). For the second examination, approximately the same
time of day was scheduled as for the first day of examination. At first height was measured with a
stadiometer (seca GmbH & Co. KG, Hamburg, Germany). Therefore, participants were advised to take
off their shoes, stand with the back to the stadiometer and touch the bar with the back of their head,
back and buttocks and back of their feet. Next, their bodyweight was measured lightly clothed and
without shoes on a digital scale to the nearest of 0.1 kg (seca GmbH & Co. KG, Hamburg, Germany).
Body composition was analyzed to a nearest of 0.1 kg using a bipolar bioelectrical impedance analyzer
(BIA) (Nutriguard M, Data Input Company, Darmstadt, Germany) and the software NutriPlus 5.4.1
(Data Input Company, Darmstadt, Germany). For the measurements, the participants were instructed
to lay down on a stretcher and rest for a few minutes (~5 min) to ensure a balanced distribution of
body fluids before the measurement. During the measurement, participants were instructed to lay
still and in a relaxed position with the limbs slightly bent from the torso. All measurements were
carried out by trained nutritionists. To avoid biases due to changing personal, the same nutritionists
conducted the measurements throughout the study after thorough instructions.
2.6. Blood Sampling and Biochemical Indices Measurement
Blood samples were drawn from the participants after an overnight fast (≥10 h) by venepuncture
of an arm vein using EDTA, serum and NaF Glucose tubes (Sarstedt AG & Co. KG, Nümbrecht,
Germany). All samples were stored at ~5 ◦C and transferred to an accredited and certified laboratory
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(Laborärztliche Arbeitsgemeinschaft für Diagnostik und Rationalisierung e.V., Hannover, Germany),
where all analyses were performed.
Triglycerides, low-density lipoprotein cholesterol (LDL) and high-density lipoprotein cholesterol
(HDL) were analyzed by a photometric method (Beckman Coulter GmbH, Krefeld, Germany).
Total cholesterol and LDL/HDL-ratio was calculated from LDL and HDL values.
Fasting glucose was determined by a photometric method (Beckman Coulter GmbH, Krefeld,
Germany). HbA1c was analyzed using high-pressure liquid chromatography (HPLC) (Bio-Rad
Laboratories GmbH, Feldkirchen, Germany). The electrochemiluminescence immunoassay method
(ECLIA) using cobas 801e (Roche Diagnostics GmbH, Mannheim, Germany) was applied to determine
insulin concentrations. To evaluate insulin resistance, the homeostatic model assessment (HOMA) was
calculated as follows: HOMA-Index = fasting insulin (µU/mL) × fasting blood glucose (mg/dL)/405 [29].
2.7. Statistical Analyses
The sample size of n = 25 per group was based on an alpha of 0.05 and 0.80 beta to detect
between-group differences, assuming an effect size of more than 0.8. With an estimated dropout rate
of 15%, a total of at least 30 participants per intervention study group were recruited. Distribution
of all data was assessed using a Shapiro-Wilk Test and Gaussian distribution. To assess differences
between groups at baseline, data from all participants was analyzed. Because all data was not normally
distributed, intergroup comparisons were assessed with Kruskal-Wallis-test while nominal data was
analyzed using Chi-square-test. For further analysis, data from all participants who took part in
both examination days was used. If the assumption of normality was not met, data was transformed
using log, square root, or reciprocal transformation. The intervention effect on all outcomes was
analyzed using a two-way repeated measures analysis of variance (ANOVA) with time (t0 and t12) and
intervention (CON, EX, EXCO, EXDC). If significant time*intervention effects were detected, a post hoc
analysis with Bonferroni correction was performed. p-values of <0.05 were considered as significant.
All statistical analyses were carried out using SPSS software (version 23.0; SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Baseline Characteristics
After screening for eligibility, 134 participants met the eligibility criteria and were randomly
assigned to one of the four study groups (Figure 1). Of all participants randomized, 72% were female
and 28% were male with a mean age of 59.2 ± 5.60 years. With a mean weight of 83.0 ± 20.2 kg and an
average BMI of 28.4 ± 5.80 kg/m2, the study population can be classified as overweight.
At baseline, there were no differences in age, weight or BMI among the study groups (Table 2).
Table 2. Baseline characteristics of all participants.
Parameter CON (n = 28) EX (n = 36) EXDC (n = 34) EXCO (n = 36) p
Sex (f/m) 21/7 24/12 26/8 25/11 0.797
Age (years) 59.3 ± 5.07 59.7 ± 6.39 60.2 ± 5.11 58.5 ± 5.69 0.563
Height (m) 169.1 ± 8.05 170.9 ± 8.73 171.0 ± 8.37 171.3 ± 8.74 0.774
Body weight (kg) 84.8 ± 22.6 81.9 ± 18.6 85.0 ± 20.3 80.7 ± 20.3 0.771
BMI (kg/m2) 29.5 ± 6.80 28.0 ± 5.51 28.95 ± 5.80 27.28 ± 5.26 0.427
SBP (mmHg) 138.0 ± 20.4 129.4 ± 14.7 133.8 ± 16.9 134.1 ± 20.1 0.332
DBP (mmHg) 81.1 ± 10.5 76.2 ± 6.16 79.2 ± 10.6 78.6 ± 7.91 0.327
Pulse 71.4 ± 8.57 74.6 ± 9.58 72.6 ± 9.23 73.8 ± 8.25 0.513
Values are given as mean ± SD. Distribution of sexes between groups was analyzed using Chi-square-test. All other
group differences were assessed with Kruskal-Wallis-Test. f = females, m = male, BMI = Body-Mass-Index,
SBP = systolic blood pressure, DBP = diastolic blood pressure.
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While protein intake stayed the same throughout the intervention and between groups, significant 
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fiber intake (p = 0.004) after the intervention. Relative fat intake was significantly higher after 12 
weeks in the CON group (+4.32 ± 8.17%E, p = 0.008), while no significant differences were found in 
the intervention groups. Similarly, CON showed a significant decrease in carbohydrate intake (−5.11 
± 6.65%E, p = 0.002). A significant decrease in carbohydrate consumption was also detected in the EX 
group (−2.76 ± 8.36%E, p = 0.034). Fiber intake increased significantly in the EXDC group (+3.00 ± 8.39 
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fatty acid intake, no differences in intake of saturated fatty acids (SFAs) or PUFAs could be found 
among the study groups. In contrast, intake of monounsaturated fatty acids (MUFAs) decreased 
significantly in the EXCO (−3.41 ± 12.0 g/day, p = 0.040) and EXDC group (−4.80 ± 9.17 g/day; p = 
0.011). 
Figure 1. Flo chart of all participants screened, rando ized, allocated and analyzed.
3.2. Physical Activity and Training Sessions
In compliance with the given instructions, there were no significant changes in physical activity
outside the intervention among the four study groups during the study period (Table S1). However,
an overall increase in basal activity could be observed in all groups, which was mostly due to increased
seasonal activities such as gardening. Additionally, no significant difference in the number of completed
training sessions was detected between the EX, EXCO and EXDC group (data not shown).
3.3. Dietary Intake
Intake of specific food groups assessed by FFQs of all study groups before and after the intervention
is presented in Table S2. In compliance with the received dietary recommendations, participants in the
EXDC group had a significant increase in fruit portions per day (p = 0.001) and vegetable portions per
day (p = 0.006) as well as fish intake per week (p < 0.001) as compared to the other groups. Except for a
significant decline of vegetable portions per day in the CON group (p = 0.018), no other significant
changes were observed.
Dietary intake from the background diet calculated from 3-day dietary food logs is shown in
Table 3. In all three exercise groups (EX, EXCO, and EXDC), average energy intake decreased about
200 kcal per day after the intervention period, yet this was not statistically different between groups.
While protein intake stayed the same throughout the intervention and between groups, significant
differences among all four study groups were found in fat (p = 0.016), carbohydrate (p = 0.015)
and fiber intake (p = 0.004) after the intervention. Relative fat intake was significantly higher after
12 weeks in the CON group (+4.32 ± 8.17%E, p = 0.008), while no significant differences were found
in the intervention groups. Similarly, CON showed a significant decrease in carbohydrate intake
(−5.11 ± 6.65%E, p = 0.002). A significant decrease in carbohydrate consumption was also detected
in the EX group (−2.76 ± 8.36%E, p = 0.034). Fiber intake increased significantly in the EXDC group
(+3.00 ± 8.39 g/day, p = 0.021) while it decreased in the EX group (−4.08 ± 6.79 g/day, p = 0.004). With
regards to fatty acid intake, no differences in intake of saturated fatty acids (SFAs) or PUFAs could be
found among the study groups. In contrast, intake of monounsaturated fatty acids (MUFAs) decreased
significantly in the EXCO (−3.41 ± 12.0 g/day, p = 0.040) and EXDC group (−4.80 ± 9.17 g/day; p = 0.011).
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Table 3. Daily dietary intake from the background diet calculated from 3-day dietary records and absolute changes (∆) at the beginning (0) and at the end (12) of
the study.
Parameter
CON EX EXDC EXCO p
t ∆ ∆ ∆ ∆






−146.8 ± 476.3 0.33412 1852.7 ± 476.0 1806.1 ± 365.4 1659.9 ± 470.9 1776.8 ± 413.5






1.05 ± 3.68 0.77212 16.7 ± 2.0 16.9 ± 3.37 17.6 ± 2.93 16.7 ± 3.26






−2.51 ± 9.04 0.01612 40.4 ± 6.24 † 36.9 ± 6.00 36.6 ± 7.93 35.6 ± 7.48






0.47 ± 8.72 0.01512 36.56 ± 5.93 † 39.8 ± 6.45 * 39.6 ± 7.76 42.39 ± 7.86






−0.78 ± 8.03 0.00412 20.04 ± 9.51 19.3 ± 6.08 † 22.0 ± 6.43 * 21.2 ± 8.80






−6.93 ± 15.2 0.06012 37.2 ± 13.6 31.0 ± 11.2 30.2 ±12.7 29.9 ± 11.1






−3.41 ± 12.0 0.03012 28.6 ± 11.8 26.0 ± 11.2 22.5 ± 11.5 * 23.9 ± 9.29 *






−1.26 ± 4.07 0.08812 12.1 ± 7.69 12.1 ± 5.75 10.3 ± 5.35 10.5 ± 5.26






−0.4 ± 0.35 0.72812 0.18 ± 0.32 0.39 ± 0.47 0.40 ± 0.43 0.19 ± 0.19






0.09 ± 0.23 0.09512 0.12 ± 0.30 0.30 ± 0.41 0.38 ± 0.42 0.14 ± 0.19
Values are given as mean ± SD. p values represent time*intervention interaction analyzed with two-way repeated measure ANOVA. In case of significance, asterisks indicate statistical
differences within groups detected with Bonferroni post hoc test (* p < 0.05; † p < 0.01). t = time in weeks, %E = percent of total energy, CHO = carbohydrates.
Nutrients 2020, 12, 2139 8 of 16
Further, the intake of EPA and DHA from the background diet did not change significantly
throughout the study between the four study groups. However, the highest increase in EPA and DHA
intake could be observed in the EXDC group (+0.15 ± 0.37 g/day DHA; +0.25 ± 0.33 g/day EPA).
3.4. Body Composition
After the intervention, a significant difference in fat mass was detected among all four study
groups (p = 0.039) (Table 4). Fat mass (FM) decreased significantly within the EXDC group (−1.41 ±
2.13 kg, p = 0.008) and the EXCO group (−1.70 ± 2.45 kg, p < 0.001). Total body water content and lean
body mass (LBM) increased significantly in CON and EXCO (CON: +0.59 ± 1.28 L, p = 0.015; +0.76 ±
1.74 kg, p = 0.018; EXCO: +0.57 ± 2.03 L p = 0.012, +0.79 ± 2.79 kg, p = 0.008). Bodyweight and BMI did
not differ significantly between all study groups after the intervention.
3.5. Markers of Glucose Metabolism
Overall, no significant differences in any markers of glucose metabolism were detected among the
study groups (Table 5). Nonetheless, the highest changes in fasting insulin and HOMA-Index was
observed within the EXDC group (−2.14 ± 4.59 µE/L and −0.56 ± 1.25), followed by the EXCO group
(−1.42 ± 2.86 µE/L and −0.27 ± 0.72).
3.6. Blood Lipids
No significant differences in blood lipids among all four study groups were detected (Table 6).
However, when compared with each other, EXCO showed the greatest decrease in triglycerides at the
end of the intervention (−10.5 ± 23.6 mg/dL).
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Table 4. Body composition and absolute changes (∆) of the four groups at the beginning (0) and at the end (12) of the study of all four study groups.
Parameter
CON EX EXDC EXCO p
t ∆ ∆ ∆ ∆






−1.16 ± 2.49 0.23612 84.6 ± 22.2 79.9 ± 18.0 83.6 ± 20.7 81.0 ± 19.0
BMI (kg/m2)







−0.37 ± 0.81 0.22912 29.4 ± 6.66 27.4 ± 5.26 28.3 ± 5.78 27.2 ± 5.01






0.11 ± 0.33 0.27912 5.39 ± 0.83 5.61 ± 0.65 5.33 ± 0.57 5.62 ± 0.79






0.57 ± 2.03 0.02812 39.7 ± 7.51 * 39.4 ± 7.61 40.5 ± 9.47 41.3 ± 9.36 *






0.79 ± 2.79 0.03112 54.0 ± 10.1 * 53.7 ± 10.1 55.3 ± 12.9 56.4 ± 12.6 †






0.71 ± 1.74 0.38812 26.4 ± 5.83 26.9 ± 6.08 27.0 ± 7.30 28.1 ± 7.18






−1.70 ± 2.45 0.03912 31.3 ± 16.5 26.2 ± 11.5 28.2 ± 12.1 † 24.7 ± 11.1 ‡
Values are given as mean ± SD. p values represent time*intervention interaction analyzed with two-way repeated measure ANOVA. In case of significance, asterisks indicate statistical
differences within groups detected with Bonferroni post hoc test (* p < 0.05; † p < 0.01; ‡ p < 0.001). t = time in weeks, BMI = body mass index, TBW = total body water, LBM = lean body
mass, BCM = body cell mass, FM = fat mass.
Table 5. Markers of glucose metabolism and absolute changes (∆) at the beginning (0) and at the end (12) of the intervention.
Parameter
CON EX EXDC EXCO p
t ∆ ∆ ∆ ∆






3.42 ± 15.97 0.66812 93.2 ± 14.3 92.6 ± 8.76 98.0 ± 25.5 92.1 ± 14.29
HbA1c (%)







−0.07 ± 0.22 0.95412 5.39 ± 0.33 5.30 ± 0.25 5.52 ± 0.72 5.31 ± 0.35
HbA1c (mol/molHB)







−0.80 ± 2.38 0.95412 35.4 ± 3.65 34.4 ± 2.76 36.8 ± 7.92 34.5 ± 3.79






−1.42 ± 2.86 0.45712 12.7 ± 10.2 9.32 ± 3.88 10.5 ± 7.21 8.81 ± 5.45
HOMA−Index







−0.27 ± 0.72 0.64012 3.08 ± 2.95 2.17 ± 1.00 2.56 ± 2.02 2.04 ± 1.41
Values are given as mean ± SD. p values represent time*intervention interaction analyzed with two-way repeated measure ANOVA. In case of significance, asterisks indicate statistical
differences within groups detected with Bonferroni post hoc test. t = time in weeks.
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Table 6. Blood lipids and absolute changes (∆) of the four groups at the beginning (0) and at the end (12) of the intervention.
Parameter
CON EX EXDC EXCO p
t ∆ ∆ ∆ ∆






−10.5 ± 23.6 0.47012 135.5 ± 89.2 111.6 ± 49.7 116.9 ± 68.9 96.9 ± 28.5






0.70 ± 25.3 0.81612 256.2 ± 59.6 232.4 ± 37.9 242.7 ± 49.7 242.9 ± 38.2






2.61 ± 7.54 0.41012 62.7 ± 14.1 67.5 ± 15.2 62.3 ± 13.8 70.6 ± 19.3






2.55 ± 18.2 0.71012 168.8 ± 47.3 147.6 ± 27.4 160.0 ± 40.6 154.6 ± 29.1






−0.08 ± 0.30 0.69412 2.81 ± 0.98 2.31 ± 0.72 2.68 ± 0.88 2.32 ± 0.68
Values are given as mean ± SD. p values represent time*intervention interaction analyzed with two-way repeated measure ANOVA. In case of significance, asterisks indicate statistical
differences within groups detected with Bonferroni post hoc test. t = time; weeks of the intervention, TC = total cholesterol, TG = triglycerides.
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4. Discussion
In this study, we show that 12 weeks of resistance and aerobic training combined with adherence
to a healthy diet or supplementation of 2 g Calanus finmarchicus oil may promote body fat loss, but did
not affect markers of glucose or lipid metabolism in overweight but otherwise healthy (no diagnosed
chronic diseases) elderly subjects.
With regards to the EXDC group, a significant increase in vegetables, fruit, and fish intake
occurred, which makes it arguable that improved diet quality supported body fat loss in this group [30].
However, it is surprising that the healthy diet did not support further changes such as an increase
in LBM. Comparable studies investigating the effect of a healthy diet with a n6/n3 ratio < 2 (dietary
recommendations, uncontrolled) or a n-3 PUFA rich diet (≥500 g fatty fish and seafood per week)
combined with 2× /week resistance training in elderly women showed an increase in leg lean mass
and increased hypertrophy of type 2 muscle fibers after 24 weeks [31,32]. However, it should be
noted that not only the fatty acid intake of the participants was modified, but also their energy
intake, macronutrient ratio, and fiber intake in the previous study. Naturally, an improved energy
and macronutrient intake will potentially improve body composition. In contrast, participants from
our study received general dietary recommendations with no specifications on caloric intake or
macronutrient distribution. Moreover, Strandberg et al., 2015 measured body composition only in
the lower extremities, whereas we used whole body measurements. The differences in estimation of
body composition make it difficult to directly compare the study outcomes. Furthermore, although an
increase in fish consumption could be observed in our study, no information about the type of fish
(lean or fatty fish) was collected. In any case, the intakes from the food logs indicated a slightly higher
intake of EPA and DHA within the EXDC group, but this was not significantly different from the other
study groups.
In contrast to the EXDC group that showed only changes in FM, the EXCO group showed several
changes in body composition, which may be mediated by CO. As health benefits from marine oils are
commonly attributed to long-chain n-3 PUFAs, this is by far the most studied component of CO. With
regard to body composition, results from a meta-analysis showed that supplementation with n3-PUFAs
as monotherapy can promote moderate weight loss, including a reduction in body fat [21]. When
combined with exercise some [33,34], but not all studies [35], reported an additional beneficial effect of
n-3 PUFAs on body fat loss in healthy active or sedentary overweight/obese participants. However,
evidence about the combined effect of n-3 PUFA supplementation and exercise on body composition in
the elderly population is limited. In elderly subjects, 12 weeks of 3× per week resistance training and
intake of ~14 g alpha-linolenic acid (ALA, C18:3n3) from 30 mL flaxseed oil showed no beneficial effect
on body composition when compared to placebo (corn oil) [36]. Even a high dose of 3 g long-chain n-3
PUFAs (1.98 g EPA and 0.99 g DHA) did not affect body composition when combined with 3× a week
resistance training over 12 weeks in male participants [37].
Contrary to findings from a recent study investigating the effect of CO and exercise in elderly
women (~70 years old with a BMI of ~26.7) that showed no effect of CO on FM but only visceral fat [38],
results from our study showed the highest loss of FM in the EXCO group. Unfortunately, we did not
measure visceral fat, but the different outcomes can be partially explained by a slightly higher BMI in
our study population. Moreover, we also found a significant increase in LBM and consequentially
body water in this group. This result would support findings from earlier studies, that found beneficial
effects of n-3 PUFAs on muscle protein synthesis [20,39]. However, existing data on the effects of n-3
PUFAs on muscle mass and strength is limited and conflicting [40]. More importantly, in this study the
CON group also showed a significant increase in LBM and body water. Although the control group
was advised to abstain from any exercise and to maintain their normal physical activity level, it is still
possible that participants of this group changed their behavior due to their participation in the study.
Indeed, a trend to an increase in physical activity could be observed but this trend was visible in all
four study groups. Even though a validated and reliable questionnaire to report physical activity was
reported, additional monitoring of physical activity via an activity tracker may have been beneficial.
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Importantly, when evaluating the changes in body composition it has to be kept in mind that the
study population was untrained, but cannot be classified as sedentary. This may indicate, that the
intensity of the moderate exercise routine as performed in this study may not have been enough to
promote changes in body composition if not supported by nutritional measures.
Findings from this study indicate that moderate exercise combined with nutritional measures
had beneficial effects in reduction of FM. While changes within the EXCD group may be explained by
improved diet quality [30], the effects in the EXCO group are likely driven through n-3 PUFAs in CO.
When discussing the effects of n-3 PUFAs it is important to consider the bioavailability of their binding
form, as this is the basic requirement for a substance to enter the body and convey its effects [41]. In CO,
most n-3 PUFAs are bound as wax esters. Although it was believed that digestion and absorption of
wax esters may not be as effective in mammals [42], a study by Gorreta and colleagues showed that
digestion of wax esters was comparable with triglycerides and ethyl esters in rats [43]. A similar result
was also found in humans when plasma concentrations of EPA and DHA were compared over a 72-h
window after intake of 4 g CO (providing 260 mg EPA and 156 mg DHA) and a fish oil supplement
containing ethyl esters (providing 465 mg EPA and 375 mg DHA), revealing equal bioavailability [44].
Regarding body fat loss, several potential mechanisms of n-3 PUFAs and their metabolites have
been proposed, including increased fat oxidation, improved adipocyte function (i.e., increased lipolysis
and reduced lipogenesis) as well as reduction of pro-inflammatory cytokines and oxidative stress in the
adipose tissue [45–47]. Increased fat oxidation is discussed as a consequence of improved β-oxidation
and biogenesis of mitochondria, which Flachs and colleagues described as a “metabolic switch” [48].
Generally, the underlying mechanisms are likely mediated by the AMP-activated protein kinase
(AMPK) and involve further activation of transcription factors. With regards to the latter, particularly
transcription factors from the family of peroxisome proliferator-activated receptors (PPAR), namely
PPARα, PPARγ, and PPARδ were shown to play a role in adipogenesis [47]. However, such mechanistic
relationships were mainly investigated in animal models or in vitro [46,49]. Therefore, it remains
unclear which dose of n-3 PUFAs exerts beneficial effects on body composition in humans. In any case,
when compared to previous human studies using supplements with >2 g of EPA + DHA, the daily
dose of n-3 PUFAs from CO was considerably lower with only ~200 mg EPA + DHA. This amount
even falls below the recommendations of the International Society for the Study of Fatty Acids and
Lipids of 0.5 g EPA + DHA per day [50]. Beyond this background, other potential mechanisms or a
combination of several pathways needs to be considered.
One compound present in CO that may influence body composition is astaxanthin, a carotene
that also serves as a natural antioxidant [51]. A recent review discussed the potential beneficial effects
of carotenes in counteracting obesity [24]. Although data in humans is limited, some studies reported
a significant decrease in adipose tissue in obese subjects after carotene supplementation [52,53]. In the
two available interventional studies, the dosage and composition of the carotenes widely varied. While
one study used a mixture containing ~24 mg of carotenes (500 µg α-carotene, 1200 µg β-carotene,
500 µg astaxanthin, 2000 µg zeaxanthin, 10 mg lutein, 10 mg lycopene) and 10 mg γ-tocopherol that
was administered twice daily [52], another study administered 9.0 mg of xanthophyll per day [53].
As those doses highly exceed the amount of astaxanthin present in 2 g of CO used in this study, the
theory of combined effects of the components present in CO is further supported.
In addition to influencing body composition, exercise was also shown to improve markers of
glucose metabolism and blood lipids in older individuals [54,55]. Therefore, we sought to identify
potential changes in such metabolic markers in the overweight study population. Although results
from our study showed no significant improvements in any metabolic markers, a trend to reduced
fasting insulin was observed in the EXDC and EXCO groups. Moreover, the highest, yet not significant,
reduction of triglycerides was observed within the EXCO group, which falls in line with results
showing a triglyceride lowering effect of n-3 PUFAs supplementation [56]. However, whether those
effects indicate further potential benefits from exercise combined with a healthy diet or CO needs to be
determined in larger scale studies.
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5. Limitations
Although BIA is an accepted tool for estimation of body composition in longitudinal studies
comparing group effects [57–59], this method also has its limitations as it was shown to be susceptible to
confounders such as vigorous physical activity, dietary intake, or hydration status [57,60,61]. However,
as all measurements were conducted at the same time in the morning after an overnight fast, acute
effects of activity or dietary intakes were minimized. Another limitation of our study is the use of a FFQ,
which did not allow checking for consumption of fatty fish versus lean fish. Next, although a validated
questionnaire to monitor the physical activity outside of the intervention was used, an additional
documentation of the physical activity level via activity trackers would have been an informative
addition. Future investigations on the effect of CO should also include a placebo group. A placebo
was not included in this setting, as we aimed to directly compare the healthy diet versus CO instead of
effects of CO only.
6. Conclusions
Taken together, results from this study indicate that a combination of moderate exercise with
a healthy diet or CO supplementation may promote body fat loss in elderly, untrained, overweight
subjects when compared to exercise only. Metabolic markers such as blood lipids and markers of
glucose metabolism did not change significantly. Future research should investigate potential effects of
a healthy diet (rich in n-3 PUFAs) vs. CO supplementation with and without exercise, particularly in
regards to body composition.
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49. Todorčević, M.; Hodson, L. The Effect of Marine Derived n-3 Fatty Acids on Adipose Tissue Metabolism and
Function. J. Clin. Med. 2016, 5, 3. [CrossRef]
50. Cunnane, S.C.; Drevon, C.A.; Harris, B.; Sinclair, A.J.; Spector, A. Report of the Sub-Committee on
Recommendations for Intake of Polyunsaturated Fatty Acids in Healthy Adults. Int. Soc. Study Fatty Acids
Lipids Retrieved Dec. 2004, 9, 2015.
51. Ikeuchi, M.; Koyama, T.; Takahashi, J.; Yazawa, K. Effects of astaxanthin in obese mice fed a high-fat diet.
Biosci. Biotechnol. Biochem. 2007, 71, 893–899. [CrossRef]
52. Canas, J.A.; Lochrie, A.; McGowan, A.G.; Hossain, J.; Schettino, C.; Balagopal, P.B. Effects of Mixed
Carotenoids on Adipokines and Abdominal Adiposity in Children: A Pilot Study. J. Clin. Endocrinol. Metab.
2017, 102, 1983–1990. [CrossRef]
53. Kakutani, R.; Hokari, S.; Nishino, A.; Ichihara, T.; Sugimoto, K.; Takaha, T.; Kuriki, T.; Maoka, T. Effect
of Oral Paprika Xanthophyll Intake on Abdominal Fat in Healthy Overweight Humans: A Randomized,
Double-blind, Placebo-controlled Study. J. Oleo Sci. 2018, 67, 1149–1162. [CrossRef]
54. Kelley, G.A.; Kelley, K.S.; Tran, Z.V. Exercise, lipids, and lipoproteins in older adults: A meta-analysis.
Prev. Cardiol. 2005, 8, 206–214. [CrossRef]
55. Forbes, S.C.; Little, J.P.; Candow, D.G. Exercise and nutritional interventions for improving aging muscle
health. Endocrine 2012, 42, 29–38. [CrossRef]
56. Weber, P.; Raederstorff, D. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids-a review.
Nutr. Metab. Cardiovasc. Dis. 2000, 10, 28–37.
57. Kyle, U.G.; Bosaeus, I.; De Lorenzo, A.D.; Deurenberg, P.; Elia, M.; Manuel Gómez, J.; Lilienthal Heitmann, B.;
Kent-Smith, L.; Melchior, J.-C.; Pirlich, M.; et al. Bioelectrical impedance analysis—part II: Utilization in
clinical practice. Clin. Nutr. 2004, 23, 1430–1453. [CrossRef]
58. Verdich, C.; Barbe, P.; Petersen, M.; Grau, K.; Ward, L.; Macdonald, I.; Sørensen, T.I.; Oppert, J.-M. Changes in
body composition during weight loss in obese subjects in the NUGENOB study: Comparison of bioelectrical
impedance vs. dual-energy X-ray absorptiometry. Diabetes Metab. 2011, 37, 222–229. [CrossRef]
59. Thomson, R.; Brinkworth, G.D.; Buckley, J.D.; Noakes, M.; Clifton, P.M. Good agreement between bioelectrical
impedance and dual-energy X-ray absorptiometry for estimating changes in body composition during
weight loss in overweight young women. Clin. Nutr. 2007, 26, 771–777. [CrossRef]
60. Tinsley, G.M.; Morales, E.; Forsse, J.S.; Grandjean, P.W. Impact of Acute Dietary Manipulations on DXA and
BIA Body Composition Estimates. Med. Sci. Sports Exerc. 2017, 49, 823–832. [CrossRef]
61. Thompson, D.L.; Thompson, W.R.; Prestridge, T.J.; Bailey, J.G.; Bean, M.H.; Brown, S.P.; McDaniel, J.B. Effects
of hydration and dehydration on body composition analysis: A comparative study of bioelectric impedance
analysis and hydrodensitometry. J. Sports Med. Phys. Fit. 1991, 31, 565–570.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
